Charles River Labs Intl buy The Goldman Sachs Group, Inc.
Start price
06.06.24
/
50%
€199.65
Target price
06.06.25
€266.42
Performance (%)
-6.11%
Price
02.07.24
€187.45
Summary
This prediction is currently active. With a performance of -6.11%, the BUY prediction for Charles River Labs Intl by The_Goldman_Sachs_Gr is down slightly. This prediction currently runs until 06.06.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Charles River Labs Intl | -2.699% |
iShares Core DAX® | -0.145% |
iShares Nasdaq 100 | 1.296% |
iShares Nikkei 225® | 1.282% |
iShares S&P 500 | 0.442% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $290.00 price target on the stock.
Ratings data for CRL provided by MarketBeat